Year: 2024

The Company generated record revenue of $10.0 million USD and positive adjusted EBITDA for the quarter ended September 30, 2024 FORT LAUDERDALE, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) — ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB US: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced the Company’s consolidated financial results for the fiscal quarter ended September 30, 2024 (“FQ1”).Generated record revenues of $10.0 million USD, an approximate 7% increase from the quarter ending June 30, 2024, and 26% compared to quarter ending September 30, 2023. Record gross profit of $3.3 million USD (approximate 33% gross profit margin). $460,297 USD of adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”) (See “Non-IFRS Financial Measures” below), an approximate increase...

SALINAS, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities including extraction, manufacturing, sales and brand management, and recently added retail dispensary management services, announces unaudited revenue and operating results for the third quarter of 2024 (ended September 30, 2024). All figures stated are in US Dollars. Third Quarter Financial Highlights:Net revenue generated for the quarter ended September 30, 2024 decreased 48% to $3.2 million, as compared to $6.2 million for the third quarter last year. Net revenue decreased 8% from $3.5 million in the second quarter of 2024.CPG revenue decreased 26% for the quarter ended September 30, 2024 compared to the quarter ended September...

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today provided a corporate update and financial results for the third quarter ending September 30, 2024. Q3 2024 Financial HighlightsCurrent liquidity available from our cash on hand and our credit facilities of approximately $63 million as of date of filing Borrowing capacity of our unsecured credit facilities increased by $10.5 million as of date of filing:ERAS/Barron facility increased from $25 million to $38 million ($33.8 million available), and; Allseas Group SA affiliate facility reduced from $27.5 million to $25.0 million (undrawn)$5.7 million cash used in operations for the quarter ended September 30, 2024 Net loss of $20.5 million...

GEORGE TOWN, Cayman Islands, Nov. 14, 2024 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, reported results for the third quarter ended September 30, 2024. All comparisons are to the same prior year period unless otherwise noted. Consolidated Water will hold a conference call at 11:00 a.m. Eastern time tomorrow to discuss the results (see dial-in information below). Third Quarter 2024 Financial Key PointsTotal revenue declined 33% to $33.4 million, due to two large construction projects that were underway in 2023 but were completed earlier this year. Meanwhile, the company’s ongoing $147 million design-build-operate desalination plant project in Hawaii continues to progress through development towards the...

Reports Second Quarter of Positive GAAP Net Income Maintains Cost Efficient Operating Profile DALLAS, Nov. 14, 2024 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled financial services holding company that provides liquidity and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2025 second quarter, which ended September 30, 2024. Commenting on the fiscal 2025 second quarter results, Beneficient management said: “We are pleased to report our second consecutive profitable quarter as a public company, which we believe positions Ben as a leading solution for liquidity and primary capital in large and growing private investment markets. With our Board of Directors having authorized up to $5 billion of fiduciary financings...

MIRAMAR, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its third quarter ended September 30, 2024.  Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stated, “In the third quarter 2024, the Company expanded our product portfolio and possible disease indications that may be treated with our immunotherapeutic compounds, consisting of compounds constructed using two different platforms. Our expanded portfolio now includes constructs with immune-cell engagers targeting tissue factor and other cell-surface antigens...

PHOENIX, Nov. 14, 2024 (GLOBE NEWSWIRE) — QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, announced financial results for the quarter ended September 30, 2024. QuoteMedia provides banks, brokerage firms, private equity firms, financial planners and sophisticated investors with a more economical, higher quality alternative source of stock market data and related research information. We compete with several larger legacy organizations and a modest community of other smaller companies.  QuoteMedia provides comprehensive market data services, including streaming data feeds, on-demand request-based data (XML/JSON), web content solutions (financial content for website integration) and applications such as Quotestream Professional desktop and mobile.  Highlights for Q3 2024 include the following:Quarterly...

Syntec continues sequential revenue growth with positive EBITDA ROCHESTER, NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) — Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical products to advanced technology defense, biomedical, and communications equipment manufacturers, today reported financial results for the first quarter of 2024. Third Quarter 2024 Financial HighlightsNet Sales of $7.86 million increased by 12.3% from $7.01 million in Q2 2024, and sales from products of $7.33 million increased by 17.2% from $6.26 million in Q3 2023. Adjusted EBITDA decreased to $1.10 million from $1.32 million in Q2 2024. Earnings per Share decreased to $0.00 from $0.01 in Q2 2024.Dean Rudy, CFO, said, “At the previous earnings call, we provided guidance for the third quarter 2024 revenue to be between $9.5 and $11.0 million....